Elevance Health Inc
ELV360.670USD
+1.600+0.45%
Cierre 12/15, 16:00（ET）Cotizaciones retrasadas 15 min
80.08BCap. mercado
14.66P/E TTM
Más Datos de Elevance Health Inc Compañía
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
Información de Elevance Health Inc
Símbolo de cotizaciónELV
Nombre de la empresaElevance Health Inc
Fecha de salida a bolsaOct 30, 2001
Director ejecutivoBoudreaux (Gail K)
Número de empleados103158
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 30
Dirección220 Virginia Avenue
CiudadINDIANAPOLIS
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal46204
Teléfono18003311476
Sitio Webhttps://www.elevancehealth.com/
Símbolo de cotizaciónELV
Fecha de salida a bolsaOct 30, 2001
Director ejecutivoBoudreaux (Gail K)
Ejecutivos de Elevance Health Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.35K
+6.87%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.92K
+13.90%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.79K
+14.35%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+3.99%
Ms. Deanna D. Strable-soethout
Ms. Deanna D. Strable-soethout
Independent Director
Independent Director
1.65K
+57.51%
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Independent Director
Independent Director
639.00
--
Mr. Robert L. Dixon, Jr.
Mr. Robert L. Dixon, Jr.
Independent Director
Independent Director
--
--
Mr. Mark B. Kaye
Mr. Mark B. Kaye
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Ratnakar V. Lavu
Mr. Ratnakar V. Lavu
Executive Vice President and Chief Digital Information Officer
Executive Vice President and Chief Digital Information Officer
--
--
Ms. Gail K. Boudreaux
Ms. Gail K. Boudreaux
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.35K
+6.87%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.92K
+13.90%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.79K
+14.35%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+3.99%
Ms. Deanna D. Strable-soethout
Ms. Deanna D. Strable-soethout
Independent Director
Independent Director
1.65K
+57.51%
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Independent Director
Independent Director
639.00
--
Desglose de ingresos
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Premiums
41.27B
0.00%
Product revenue
6.04B
0.00%
Service fees
2.11B
0.00%
Reconciliation
355.00M
0.00%
Operating revenue - affliated
0.00
0.00%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Premiums
41.27B
0.00%
Product revenue
6.04B
0.00%
Service fees
2.11B
0.00%
Reconciliation
355.00M
0.00%
Operating revenue - affliated
0.00
0.00%
Estadísticas de accionistas
Actualizado: mar., 18 de nov
Actualizado: mar., 18 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
10.30%
BlackRock Institutional Trust Company, N.A.
5.31%
State Street Investment Management (US)
4.66%
Wellington Management Company, LLP
2.98%
Sanders Capital, LLC
2.60%
Otro
74.16%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
10.30%
BlackRock Institutional Trust Company, N.A.
5.31%
State Street Investment Management (US)
4.66%
Wellington Management Company, LLP
2.98%
Sanders Capital, LLC
2.60%
Otro
74.16%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
49.97%
Investment Advisor/Hedge Fund
30.87%
Pension Fund
2.77%
Bank and Trust
2.31%
Hedge Fund
2.17%
Research Firm
2.06%
Sovereign Wealth Fund
1.41%
Family Office
0.27%
Family Office
0.27%
Otro
7.92%
Participación institucional
Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
3063
205.92M
97.95%
+22.74K
2025Q3
3138
205.95M
97.05%
-3.45M
2025Q2
3116
209.73M
96.68%
-566.57K
2025Q1
3115
208.90M
96.86%
-10.38M
2024Q4
3105
212.00M
93.76%
+298.05K
2024Q3
2993
212.22M
94.67%
-2.15M
2024Q2
2959
214.26M
94.25%
+1.04M
2024Q1
2925
213.00M
94.22%
-6.19M
2023Q4
2869
213.96M
93.90%
-1.80M
2023Q3
2746
215.71M
93.86%
-2.17M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
22.75M
10.1%
-140.75K
-0.61%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
11.62M
5.16%
-183.35K
-1.55%
Jun 30, 2025
State Street Investment Management (US)
10.57M
4.69%
-78.72K
-0.74%
Jun 30, 2025
Wellington Management Company, LLP
6.32M
2.81%
+523.40K
+9.03%
Jun 30, 2025
Sanders Capital, LLC
5.83M
2.59%
+1.15M
+24.66%
Jun 30, 2025
T. Rowe Price Associates, Inc.
7.75M
3.44%
-1.01M
-11.48%
Jun 30, 2025
Geode Capital Management, L.L.C.
5.09M
2.26%
-72.83K
-1.41%
Jun 30, 2025
Artisan Partners Limited Partnership
3.68M
1.63%
+324.40K
+9.68%
Jun 30, 2025
First Eagle Investment Management, L.L.C.
3.20M
1.42%
-41.22K
-1.27%
Jun 30, 2025
Harris Associates L.P.
2.29M
1.02%
+7.41K
+0.32%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares U.S. Healthcare Providers ETF
4.43%
Monarch Dividend Plus Index ETF
3.25%
John Hancock Fundamental All Cap Core ETF
2.45%
GMO US Quality ETF
2.35%
VictoryShares Free Cash Flow ETF
2.32%
Bushido Capital US Equity ETF
2.2%
State Street SPDR S&P Health Care Services ETF
2.11%
First Eagle Global Equity ETF
2.03%
First Trust Total US Market AlphaDEX ETF
1.75%
First Trust Health Care Alphadex Fund
1.71%
Ver más
iShares U.S. Healthcare Providers ETF
Proporción4.43%
Monarch Dividend Plus Index ETF
Proporción3.25%
John Hancock Fundamental All Cap Core ETF
Proporción2.45%
GMO US Quality ETF
Proporción2.35%
VictoryShares Free Cash Flow ETF
Proporción2.32%
Bushido Capital US Equity ETF
Proporción2.2%
State Street SPDR S&P Health Care Services ETF
Proporción2.11%
First Eagle Global Equity ETF
Proporción2.03%
First Trust Total US Market AlphaDEX ETF
Proporción1.75%
First Trust Health Care Alphadex Fund
Proporción1.71%
Dividendos
Un total de
6.19B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Oct 15, 2025
ELV.NB Final Cash Dividend of gross USD 1.71 paid on Dec 19, 2025 going ex on Dec 05, 2025
Dec 05, 2025
Dec 19, 2025
Dec 05, 2025
Jul 17, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Sep 25, 2025 going ex on Sep 10, 2025
Sep 10, 2025
Sep 25, 2025
Sep 10, 2025
Apr 22, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Jun 25, 2025 going ex on Jun 10, 2025
Jun 10, 2025
Jun 25, 2025
Jun 10, 2025
Jan 23, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Mar 25, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 25, 2025
Mar 10, 2025
Oct 17, 2024
ELV.NB Final Cash Dividend of gross USD 1.63 paid on Dec 20, 2024 going ex on Dec 05, 2024
Dec 05, 2024
Dec 20, 2024
Dec 05, 2024
Jul 17, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Sep 25, 2024 going ex on Sep 10, 2024
Sep 10, 2024
Sep 25, 2024
Sep 10, 2024
Apr 18, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Jun 25, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 25, 2024
Jun 10, 2024
Jan 26, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Mar 22, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 22, 2024
Mar 07, 2024
Oct 18, 2023
ELV.NB Final Cash Dividend of gross USD 1.48 paid on Dec 21, 2023 going ex on Dec 05, 2023
Dec 06, 2023
Dec 21, 2023
Dec 05, 2023
Jul 19, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Sep 22, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 22, 2023
Sep 07, 2023
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Elevance Health Inc?
Los cinco principales accionistas de Elevance Health Inc son:
The Vanguard Group, Inc. posee 22.75M acciones, lo que representa el 10.10% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 11.62M acciones, lo que representa el 5.16% del total de acciones.
State Street Investment Management (US) posee 10.57M acciones, lo que representa el 4.69% del total de acciones.
Wellington Management Company, LLP posee 6.32M acciones, lo que representa el 2.81% del total de acciones.
Sanders Capital, LLC posee 5.83M acciones, lo que representa el 2.59% del total de acciones.
The Vanguard Group, Inc. posee 22.75M acciones, lo que representa el 10.10% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 11.62M acciones, lo que representa el 5.16% del total de acciones.
State Street Investment Management (US) posee 10.57M acciones, lo que representa el 4.69% del total de acciones.
Wellington Management Company, LLP posee 6.32M acciones, lo que representa el 2.81% del total de acciones.
Sanders Capital, LLC posee 5.83M acciones, lo que representa el 2.59% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Elevance Health Inc?
Los tres principales tipos de accionista de Elevance Health Inc son:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
¿Cuántas instituciones poseen acciones de Elevance Health Inc (ELV)?
A fecha de 2025Q4, 3063 instituciones poseen acciones de Elevance Health Inc, con un valor de mercado combinado de aproximadamente 205.92M, lo que representa el 97.95% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en 0.90%.
¿Cuál es la mayor fuente de ganancias de Elevance Health Inc?
El FY2025Q2, el segmento empresarial Premiums generó la ganancia más alta para Elevance Health Inc, ascendiendo a 41.27B y representando el --% de la ganancia total.
